Viemed Healthcare (VMD) Income towards Parent Company (2018 - 2026)

Viemed Healthcare has reported Income towards Parent Company for 9 years, with the latest figure at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Income towards Parent Company changed 0.11% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $15.4 million (up 22.87% YoY), and the FY2025 full-year result was $15.4 million, up 34.77% from the prior year.
• Income towards Parent Company for Q1 2026 stood at $2.7 million, down from $5.8 million in the prior quarter.
• The five-year high for Income towards Parent Company was $5.8 million in Q4 2025, with the low at $967000.0 in Q2 2022.
• Historically, Income towards Parent Company has averaged $2.7 million across 5 years, with a median of $2.7 million in 2025.
• Annual changes were most pronounced in 2022 — Income towards Parent Company sank 41.03% — and 2023, when it surged 176.68%.
• Viemed Healthcare's Income towards Parent Company stood at $2.4 million in 2022, then soared by 42.62% to $3.5 million in 2023, then gained by 27.24% to $4.4 million in 2024, then soared by 31.46% to $5.8 million in 2025, then slumped by 53.35% to $2.7 million in 2026.
• The last three Income towards Parent Company figures came in at $2.7 million (Q1 2026), $5.8 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.